You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

lerodalcibep

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hypercholesterolemia, Atherosclerotic Ischemic Disease Trial in Heidelberg, London (lerodalcibep, Inclisiran)

Enrolling by invitation
  • Hypercholesterolemia
  • Atherosclerotic Ischemic Disease
  • Nantes, Cedex 01, France
  • +6 more
Nov 3, 2022

Cardiovascular Diseases, Hyper-LDL-cholesterolemia Trial in Cincinnati (lerodalcibep)

Active, not recruiting
  • Cardiovascular Diseases
  • Hyper-LDL-cholesterolemia
  • lerodalcibep
  • Cincinnati, Ohio
  • +2 more
Nov 3, 2022

Hypercholesterolemia Trial in Cincinnati (lerodalcibep)

Completed
  • Hypercholesterolemia
  • lerodalcibep
  • Cincinnati, Ohio
    Metabolic & Atherosclerosis Research Center (MARC)
Jul 13, 2022

Cardiovascular Risk Factor, Cardiovascular Diseases, Cardiovascular Stroke Trial in India, Israel, United States (lerodalcibep,

Active, not recruiting
  • Cardiovascular Risk Factor
  • +3 more
  • lerodalcibep
  • Placebo
  • Cincinnati, Ohio
  • +5 more
Nov 3, 2022

Heterozygous Familial Hypercholesterolemia Trial in Worldwide (lerodalcibep)

Active, not recruiting
  • Heterozygous Familial Hypercholesterolemia
  • lerodalcibep
  • Cincinnati, Ohio
  • +6 more
Nov 3, 2022

Homozygous Familial Hypercholesterolemia Trial in Worldwide (lerodalcibep, evolocumab)

Active, not recruiting
  • Homozygous Familial Hypercholesterolemia
  • Evanston, Illinois
  • +11 more
Jul 13, 2022

Cardiovascular Disease With Mention of Arteriosclerosis, Elevated Cholesterol, Familial Hypercholesterolemia Trial in Worldwide

Enrolling by invitation
  • Cardiovascular Disease With Mention of Arteriosclerosis
  • +2 more
  • lerodalcibep
  • Evanston, Illinois
  • +11 more
Aug 6, 2021